The business combination of Frazier Lifesciences Acquisition Corp. (FLAC/W/U) and NewAmsterdam Pharma Holding B.V. became effective today, November 22, 2022. As a result of the business combination, the Class A Ordinary Share, Warrant, and Unit of Frazier Lifesciences Acquisition Corp. (FLAC/W/U) will be suspended from trading. The suspension details are as follows:
| Company Name/Issue: |
Frazier Lifesciences Acquisition Corp. Class A Ordinary Shares |
| CUSIP#: |
G3710A105 |
| Symbol: |
FLAC |
| Last Trading Date: |
November 22, 2022 |
| Marketplace Effective Date for Suspension: |
November 23, 2022 |
| Merger Consideration: |
One (1) NewAmsterdam Pharma Company N.V Ordinary Share for each share held. |
| Company Name/Issue: |
Frazier Lifesciences Acquisition Corp. Warrant |
| CUSIP#: |
G3710A113 |
| Symbol: |
FLACW |
| Last Trading Date: |
November 22, 2022 |
| Marketplace Effective Date for Suspension: |
November 23, 2022 |
| Merger Consideration: |
One (1) NewAmsterdam Pharma Company N.V Warrant expiring 11/22/2027 for each warrant held. |
| Company Name/Issue: |
Frazier Lifesciences Acquisition Corp. Unit |
| CUSIP#: |
G3710A121 |
| Symbol: |
FLACU |
| Last Trading Date: |
November 22, 2022 |
| Marketplace Effective Date for Suspension: |
November 23, 2022 |
| Merger Consideration: |
Unit will separate into its components. |
As a result of the merger the combined company will be listed on the Nasdaq Capital Market. The details are as follows:
| Company: |
NewAmsterdam Pharma Company N.V. Ordinary Share
|
| CUSIP#: |
N62509109
|
| Symbol: |
NAMS |
| Marketplace Effective Date: |
November 23, 2022
|
| Company: |
NewAmsterdam Pharma Company N.V. Warrant expiring 11/22/2027
|
| CUSIP#: |
N62509117
|
| Symbol: |
NAMSW |
| Marketplace Effective Date: |
November 23, 2022
|
If you would like to register as a market maker in NAMS or NAMSW, contact Nasdaq Trading Services at +1 212 231 5100.
RSS Feeds
Product Login
